Breast Biopsy Devices Market Report with Top Key Players, Types, and Application

Global breast biopsy devices market is forecasted to generate a revenue of $1.4 billion by 2023, P&S Market Research.
 
 
Spread the Word
Listed Under

Tag:
* Breast Biopsy Devices Market

Industry:
* Reports

Location:
* Alamo - California - US

Subject:
* Reports

ALAMO, Calif. - Aug. 20, 2019 - PRLog -- The growth is mainly led by product and technological innovations, increasing incidence of breast cancer cases, rising propensity for minimally invasive surgeries, and mounting number of breast cancer screening programs.

On the basis of the procedure conducted for breast biopsy (https://www.psmarketresearch.com/market-analysis/breast-biopsy-devices-market), the market is categorized into vacuum-assisted, core needle, fine needle aspiration, and surgical biopsy. Vacuum-assisted biopsies have been accounting for the largest share in the breast biopsy devices market till now. It is also expected to be the fastest growing category during the forecast period. This can be mainly attributed to its various advantages, such as its ability to precisely locate the area of abnormality using imaging guidance, so that samples are removed only from the region of interest.

During the forecast period, the breast biopsy devices industry is expected to witness the fastest growth in in Asia-Pacific (APAC), owing to growing geriatric population, increasing prevalence of breast cancer, growing awareness about breast cancer, rising healthcare expenditure, per capita income, and increasing research in breast biopsy devices in the region. According to National Institute of Cancer Prevention and Research, breast cancer is the most common cancer in women in India and accounts for about a quarter of all cancers in women in Indian cities, and the average age for breast cancer in India is almost a decade lower than that in the West.

In August 2017, Hologic Inc. announced the commercial availability of Brevera breast biopsy system with CorLumina imaging technology, in the U.S. The Brevera system provides clinicians with more information at the point of care and results in significant cost and time savings without compromising with accuracy or patient health outcomes.

Some of the other major players operating in the breast biopsy devices market include Danaher Corporation, Argon Medical Devices Inc., Becton, Dickinson and Company, Sterylab S.R.L., Scion Medical Technologies LLC, Planmed Oy, Medtronic plc, and Cook Medical LLC.

Media Contact
Pramod Kumar
***@psmarketresearch.com
13479606455
End
Email:***@psmarketresearch.com
Posted By:***@psmarketresearch.com Email Verified
Tags:Breast Biopsy Devices Market
Industry:Reports
Location:Alamo - California - United States
Subject:Reports
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
P&S Intelligence News
Trending
Most Viewed
Daily News

Most Viewed
Daily News
PTC News

Aug 20, 2019 News



Like PRLog?
9K2K1K
Click to Share